Literature DB >> 31050632

Circulation of imipenem-resistant Acinetobacter baumannii ST10, ST2 and ST3 in a university teaching hospital from Tehran, Iran.

Soha Seyyedi Abhari1, Farzad Badmasti2, Leila Modiri1, Mohamad Mehdi Aslani2, Mehdi Asmar3.   

Abstract

PURPOSE: Multi-drug resistant (MDR) Acinetobacter baumannii has introduced a worldwide health crisis. The purposes of this study were to characterize the clonal relatedness among MDR clinical strains and to introduce a new two-locus typing method confirmed by multi-locus sequence typing (MLST).
METHODOLOGY: In this study, we determined antimicrobial resistance, detected genes associated with carbapenem resistance and characterized clonal relatedness among 99 clinical isolates extracted from 82 hospitalized inpatients in a university hospital.
RESULTS: Of the 99 A. baumannii isolates, 92.9% (92/99) were resistant to imipenem and 97.9% (97/99) had an MDR profile. We found that the high prevalence of blaVIM [94.9% (94/99)] and blaOXA-23-like [93.93% (93/99)] is the main mechanism of carbapenem resistance. This study proposes a new two-locus typing (blaOXA-51-like and ampC) method for the rapid identification of clonal complexes (CCs). The results of this method and confirmation by MLST show that clinical isolates carry blaOXA-68 as well as ampC-10 or ampC-20 genes belonging to CC10 (ST10); blaOXA-66 and ampC-2 belonging to CC2 (ST2); and blaOXA-71 and ampC-3 belonging to CC3 (ST3). One isolate had blaOXA-90 with an undetermined allele number of ampC belonging to ST513.
CONCLUSION: The high prevalence of MDR strains and the circulation of four limited clones, including ST10 (45/99), ST2 (41/99), ST3 (12/99) and ST513 (1/99), in the clinical setting highlights the importance of a rigorous infection control programme. The two-locus typing method has more discrimination than the application of each method separately and it could be applied for the rapid determination of the CC without performing MLST.

Entities:  

Keywords:  Multi-drug resistant (MDR) Acinetobacter baumannii; carbapenemase genes; clonal relatedness

Mesh:

Substances:

Year:  2019        PMID: 31050632     DOI: 10.1099/jmm.0.000987

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  The face of hypervirulent Klebsiella pneumoniae isolated from clinical samples of two Iranian teaching hospitals.

Authors:  Rahimeh Sanikhani; Mohammad Moeinirad; Hamid Solgi; Azar Hadadi; Fereshteh Shahcheraghi; Farzad Badmasti
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-08-31       Impact factor: 3.944

2.  Emergence of K1 ST23 and K2 ST65 hypervirulent klebsiella pneumoniae as true pathogens with specific virulence genes in cryptogenic pyogenic liver abscesses Shiraz Iran.

Authors:  Maryam Sohrabi; Mahvash Alizade Naini; Alireza Rasekhi; Mana Oloomi; Farzad Moradhaseli; Abbas Ayoub; Abdollah Bazargani; Zahra Hashemizadeh; Fereshteh Shahcheraghi; Farzad Badmasti
Journal:  Front Cell Infect Microbiol       Date:  2022-08-09       Impact factor: 6.073

3.  In Silico Analyses of Extracellular Proteins of Acinetobacter baumannii as Immunogenic Candidates.

Authors:  Sepideh Fereshteh; Narjes Noori Goodarzi; Amin Sepehr; Morvarid Shafiei; Soheila Ajdary; Farzad Badmasti
Journal:  Iran J Pharm Res       Date:  2022-05-09       Impact factor: 1.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.